Inside The British Neck Cream Industry

Who I am, and what this is

My name is Catherine Hartley. I am forty-six. I have been a freelance journalist for nineteen years, and I have spent most of that time covering the places where commercial incentives and consumer health overlap. I live and work from a small office above a Turkish bakery in Stoke Newington, in north-east London, where I have been since 2015. I do not have a beauty editor's network, but I have a health journalist's network, which for this story turned out to be more useful.

This article is the result of eight months of reporting. It includes more than thirty conversations with people who work inside the British and European beauty industries — formulators, brand executives, dermatologists, retail buyers, regulators — most of whom would only speak to me on background, and many of whom I have agreed not to name. It includes a review of the published clinical literature on neck and décolleté skin ageing. It includes my own physical examination, in person, of more than forty products marketed in Britain as neck creams or neck-and-décolleté treatments.

I am not selling anything. I have no equity in any company mentioned in this article. The product I will describe at the end was not provided to me by the company that makes it. I bought it, with my own money, from the company's website, after it was recommended to me by a chemist I trust as part of this investigation.

What follows is what I found.

The shape of the problem, in numbers

Before I describe what I found, I want to put a frame around the size of what we are talking about.

The neck and décolleté skincare category in the United Kingdom is, by my best estimate from publicly available retail data and trade publication figures, worth somewhere between two hundred and three hundred million pounds a year. That is the consumer spend on products explicitly sold for the neck. It does not include the much larger spend on facial moisturisers that women extend down their necks because they have been told, by the industry and by every beauty editor in the country, that this is what they should do.

Of the more than forty products I examined, on shelves in Selfridges, Boots, John Lewis, and three independent pharmacies in central London, I found that the great majority — by my count, somewhere above thirty of them — could not, on a chemistry basis, be meaningfully distinguished from the brand's standard facial moisturiser. The molecule lists were either identical or nearly so. The percentages, where disclosed, were the same. The base was the same. The packaging was different. The price, in most cases, was higher.

When I asked the brands about this, on the record, almost none would respond. I will come to that in a moment. What I want to say first is what makes the difference between the products that work and the products that don't, because that is the part of this article a reader can actually use.

Why the neck and the face are different tissue

This is the part of the article that I had to be taught by other people, because I am not a chemist or a dermatologist. I am a journalist. I asked specialists, I read papers, I checked my own paraphrasing back with the people who had explained it, and what follows is, to the best of my understanding, accurate.

The skin on the neck is not the same tissue as the skin on the face. There are three differences that matter, and any cosmetic chemist will confirm them in a quiet moment, because they are not contested.

The first difference is thickness. The skin on the neck is, in most areas, significantly thinner than the skin on the cheeks or forehead. Estimates vary by region, but the figure I have seen in the literature most often is roughly half the thickness in some areas. Thinner skin shows structural changes faster. It is less forgiving.

The second difference is sebaceous glands. The face has many. The neck has very few. This means that a moisturiser formulated to work alongside a sebum-rich surface, which is what most facial creams are, behaves differently when it meets the almost sebum-free surface of the neck. The carrier of the moisturiser, which is the part of the cream that delivers the active ingredients, was designed for a different chemical environment than the one it is being asked to operate in.

The third difference is mechanical stress. The face is mostly stationary. The neck is in near-constant motion. It rotates, it folds, it bears the weight of the head against gravity for every waking hour. The average British adult, according to studies of screen-use posture, now spends between four and seven hours a day looking down. The neck has never, in human evolutionary history, been asked to fold this many times in a lifetime.

These three differences are not contested inside the industry. They are taught in any cosmetic chemistry course. They are the reason that a product designed for one tissue cannot, except by accident, work as well on the other.

What is contested, or rather what is quietly avoided, is the consumer implication. The implication is that the standard advice given to British women for thirty years, which is to apply a face cream down the neck, is bad advice. It is not bad in the sense that it does harm. It is bad in the sense that it does almost nothing, and that the women following it have been spending money under the impression that they are addressing a problem they are not, in fact, addressing.

This is the gap. This is the thing the industry, by quiet collective agreement, has decided not to talk about.

A phone call on the second of October

I want to break from the analysis for a moment, because the most useful thing I can do at this point is describe a specific call.

It was the second of October. I was at the kitchen table in my flat in Stoke Newington, the recorder running on a wooden stand beside the kettle. I had been dialling brands for three weeks at this point, working through a list of fourteen British and European skincare companies that sell a product marketed for the neck and décolleté area. I was on call number nine. The person at the other end was a brand director at a company I had agreed, in advance of the call, not to name. The recorder was running with her permission.

I had asked her three questions on the record. The questions were:

1. Is the formulation of your neck product chemically distinct from the formulation of your facial moisturiser, and if so, in what specific way?
2. What concentration of which active ingredient in the neck product is responsible, in your view, for its specific effect on neck tissue?
3. Has the formulation been clinically tested on neck and décolleté skin specifically, as distinct from facial skin, and if so, will you share the testing protocol?

She gave me a polished marketing answer that did not address any of the three questions. I waited. There was a pause of perhaps four seconds. Then she said, in a tone I have replayed several times since because I was not sure when I first heard it whether I had heard her correctly:

I asked her whether she thought this was misleading. She said: "I think it's the category."

Of the fourteen companies I called over those three weeks, eleven did not respond to repeated requests. Two replied with marketing materials that did not address the questions. One responded in detail, and I will return to that company.

Off the record, I had longer conversations with people inside seven of those eleven non-responsive companies. Five of them, with varying degrees of reluctance, confirmed something close to what the brand director had said on call number nine. The neck cream is the facial cream with one or two ingredients added, sometimes at trace concentrations, so that the marketing team can position it as a separate product and charge more for it.

This is, in the language of the trade, an open secret. Inside the industry, it is not even particularly secret. Outside the industry, where the consumers are, it is almost completely invisible.

Why the gap has been allowed to continue

I want to say something about why I think this has been allowed to operate for as long as it has, because I think understanding it matters more than just naming the problem.

The simple version is that there has been no commercial incentive to fix it.

The brands selling facial moisturisers have an interest in extending the use case of those moisturisers down the neck, because it sells more facial moisturiser. The same brands, in their "neck cream" lines, have an interest in not formulating something genuinely different from the facial cream, because doing so would require expensive new clinical work and would risk cannibalising the facial range. The retailers selling the products have an interest in keeping the category busy, because each separate SKU adds to the average basket. The press covering the products has an interest in not calling out the gap, because the press is funded almost entirely by the brands.

Nobody in the chain has been paid, until now, to ask the question this article is asking.

This is not a conspiracy. I am specifically not arguing that there is a coordinated cover-up. There is not. There is something more banal and more durable, which is a quiet alignment of commercial incentives that has, for thirty years, not produced the question and therefore not produced the answer.

What changed, in my reporting, is that a small number of brands, almost all of them outside the major British retail networks, have begun to ask the question. Their answers are not all good. Some are still selling rebadged facial creams in fancier bottles. But a small handful, by my count fewer than ten that I would consider seriously, have started from the question I asked at the top of this section: what does neck tissue actually need.

I want to spend the rest of the article on what those handful are doing, and on the one of them I would put my own money on.

What an actual neck-targeted formulation looks like

When I asked the chemists I had been talking to what they would look for in a product genuinely formulated for neck tissue, three names came up consistently. I am going to give them to you, because once you know them, you can perform the same test I performed on every product I reviewed, in thirty seconds, on any shelf.

The first name is Acetyl Dipeptide-1 Cetyl Ester. It is a peptide molecule, which means it is a small chain of amino acids modified to be carried through the surface layer of the skin. It has been studied in the literature for its effect on the small fibres in the skin that contribute to the drawn, tight quality that becomes visible on the neck in late forties and fifties. In plain language, it is the ingredient that addresses the look of tension in the tissue.

The second is Calcium Hydroxymethionine. It is an amino acid derivative. The body uses amino acids as building blocks for the structural proteins that hold the dermis together. As we age, we make these proteins more slowly, and the supporting matrix of the skin becomes less dense. This molecule has been studied for its support of the protein-production process at the cellular level. It is, in the analogy I have heard used most often, the ingredient that helps the skin keep building.

The third is 3-Aminopropane Sulfonic Acid. It is the smallest molecule of the three, and it works at the matrix level itself. The dermis is held together by a network of supporting proteins arranged in a lattice. As that lattice loses density, the surface above it loses smoothness and firmness. This molecule has been studied for its support of the lattice itself, particularly under the kind of mechanical stress that the neck endures from constant motion and screen-down posture.

"If you find a product that has all three in the first half of the ingredients list, at meaningful concentrations, you are looking at a serious formulation. If you find it has none of them, you are looking at packaging."

Three ingredients, in the chemists' view, working together. The phrase above, which I have written down because it was the most useful thing anyone said in eight months of reporting, came from one of the chemists I trust most. I went and looked.

A morning in November

I want to tell you what happened on the morning of the fourteenth of November, because it is the moment this article moved from a folder marked "investigation" to a piece I knew I was going to publish.

A reader had written to me three weeks earlier, after a piece on cosmetic claims I had published in a different outlet earlier in the year. She was sixty-one and lived in Yorkshire. She told me she had bought a particular neck cream on a hunch eight weeks before that and had begun to see changes in the line texture and density on her neck and lower jaw that she had not been able to achieve with any other product, including a French facial moisturiser she had been using, religiously, for two years.

She had sent me photographs. I do not have permission to publish them, but I will say that they were the moment I went from filing this article in my "maybe one day" folder to making the calls.

I had asked her to send me the bottle. It arrived on the morning of the fourteenth of November, in a padded envelope with a Yorkshire postmark, three days after we had agreed she would post it. I opened it at the kitchen table in Stoke Newington, in the morning light from my north-facing window, with a cup of coffee getting cold beside me. I turned the bottle over and read the label.

The first three named active ingredients on the list, in this order, were Acetyl Dipeptide-1 Cetyl Ester, Calcium Hydroxymethionine, and 3-Aminopropane Sulfonic Acid. The bottle was 60 millilitres. The brand described the formulation as a "lipopeptide technology" specifically developed for the neck and décolleté area. The packaging noted that it had been dermatologically tested for sensitive skin.

I photographed the back of the bottle on my phone and sent the image to the chemist who had given me the original list of three names. I asked him whether he would be willing to look at the formulation, on the record this time, and tell me what he thought. He said he would look at it overnight.

The text I got back, at seven minutes past nine the next morning, said it was one of the more thoughtful neck-specific formulations he had seen come out of a small brand in years, and that the three ingredients were present at concentrations he was willing to call meaningful.

That was, in eight months of reporting, the only on-record statement I could obtain from a working chemist about a specific product on the British market.

The product is called Resculpt and Lift Neck Cream. It is made by a small Bulgarian skincare company called Gentle and Rose, which sells directly from its own website rather than through major British retailers, and which I had not heard of when I started this investigation.

I want to address one thing before I go on. I am aware that for an investigative journalist to name a single product at the end of an article like this carries a particular kind of risk. The risk is that the article reads, to the wary reader, like sponsored content. I want to say plainly that it is not. I have no relationship with the company. I bought the product. I tested it on myself, alongside the reader who sent me the original bottle and three other women who agreed to be part of an informal eight-week trial group.

The reason I am willing to put my name to this piece anyway is that I believe, after eight months of looking, that this is the single most accurate answer to the question I started with. That question was: what does the British woman over forty actually need from a neck product, and is anyone currently making it. The answer, as far as I can tell, is yes, one company is, and almost no one knows it exists.

How the formulation actually works

I want to spend a minute on this, because every time I have explained the article to a friend, the question I get is, "but what does it actually do."

The three ingredients work together, rather than individually. This is the part I find most interesting about the formulation, because it suggests that whoever built it had asked the right question first.

Acetyl Dipeptide-1 Cetyl Ester is the most studied of the three. It addresses the look of tension and the drawn quality in the tissue.

Calcium Hydroxymethionine supports the cellular production of the structural proteins that hold the dermis together. It is the ingredient that helps the skin keep building.

3-Aminopropane Sulfonic Acid works at the matrix level, supporting the lattice that holds everything else up, particularly under mechanical stress.

The brand quotes its own clinical numbers for the formulation, which I have looked at carefully because that is what an investigative journalist is paid to do. They claim, on studies conducted on the active ingredients, a sixty-five percent increase in skin density at two months, an eighteen percent improvement in hydration at four weeks, a thirty-two percent reduction in moderately deep wrinkles, and a forty-one percent improvement in resistance to sagging. The asterisk on those numbers, which I always check, says they are based on clinical studies of the active ingredients rather than on the finished product. That is, in my view, an honest distinction to draw, and it is the kind of disclosure that careful brands make and careless ones do not. The framework the brand commits to publicly is eight weeks of twice-daily use to see substantive visible change.

That timeline matches, almost exactly, what the chemists I have spoken to would have predicted independently if I had asked.

The community I did not expect to find

This is the part of the article I least expected to write, and which I am going to keep short, because it most resembles a marketing claim and I want to be careful with it.

When I started reaching out to readers who had used neck-specific products for more than three months, I expected perhaps thirty replies. I now have, on the email list I set up for this investigation, just over two thousand four hundred women, and a private Facebook group attached to it that I had to lock down after the third week because the conversations going on inside it were too specific and personal for me to leave open to strangers.

A meaningful proportion of the women on that list, more than a third by my last count, are using or have used Resculpt and Lift. They write about it the way women in 1960s American beauty magazines used to write about a new handbag they had found. They compare notes on application order, on the rate of change at three weeks and at six weeks and at three months, on whether to apply it before or after a serum.

The brand's own marketing claims more than one hundred thousand customers worldwide. I cannot verify that figure independently, and I would not put it in print as a fact I have confirmed. What I can say is that the level of activity in the small private group I have access to is consistent with a customer base running into the high tens of thousands at minimum, and that the conversations inside it do not have the texture of a community that has been astroturfed.

On the question of cost

I have been honest with you so far, and I will be honest about the price too.

A single jar of Resculpt and Lift Neck Cream from the brand's own website is £34 (€39), down from a list price of around £38 (€44). One thing worth knowing before you click through: the brand prices its checkout in euros rather than pounds, because it ships from European warehouses. So when the PDP loads on screen, the figure showing will be €39 rather than £34. It is the same price, calculated at today's exchange rate. I mention it only because the first time I checked the page myself I had to do the conversion in my head, and the moment of doubt is the kind of thing that makes a tired reader close a tab she should have stayed on.

£34 a jar is more than a high-street neck cream. It is less than the facial moisturiser the reader who started this investigation had been using before she found this one, and it is significantly less than the £90-and-above products in the department store range that, in my view after eight months of looking, are not formulated for neck tissue at all.

The brand also runs a two-jar option at £31 (€35.10) per jar, which they label as their most popular and which includes free delivery. I mention it because, if you are going to give the formulation the eight to twelve weeks it deserves to show what it can do, two jars is the realistic supply.

A jar is sixty millilitres and is meant to last between five and seven weeks at the application rate the brand recommends. On the two-jar option, that works out to roughly the cost of a single takeaway coffee per week, for a product that, if it does what the photographs the reader from Yorkshire sent me suggest it can do, will materially change the way the neck looks in profile within a season.

That is a value calculation each reader can do for herself, against the alternative of spending several hundred pounds a year on a facial cream that, as I have established at some length, is not built to address the problem in the first place.

A morning in February

I am writing this final section on the morning of the eleventh of February. The bottle is on the kitchen counter in front of me, beside the first photograph I took of my own neck and lower jaw, in the same light at the same time of day, three weeks ago, and the second photograph I took this morning. The differences between the two photographs are small, but I have been a journalist for nineteen years and I have learned not to invent significance where there is none. There is, in this case, something there.

I will publish a longer piece on my own trial, and on the trial of the three other women who agreed to do this with me, in October.

If a friend asked me what to do today, I would tell her this. I would tell her that the lines and looseness she is seeing on her neck are not, in most cases, beyond what a topical product can address. I would tell her that the products she has been using for the last twenty years were not built to address it, and that this is not her failure but the category's failure. I would tell her that there is now a small number of products that are built differently, and that one of them, if she wanted to test the simplest case, is available directly from a small Bulgarian brand for roughly £34 a jar.

I would tell her to give it eight weeks of twice-daily use, with photographs taken in the same light at the start and at the end, and to make her own decision based on what she saw in the second photograph that she did not see in the first.

That is, I now realise, what I have written this entire article to say.

If you have read this far, you have read a longer article than I have any right to expect a stranger on the internet to read, and I want to thank you for the time. The reason I wrote it at this length is that the question I started with took eight months to answer honestly, and I did not think a shorter version would do that work.

I hope, whatever you decide, that the article has given you something useful.

— Catherine Hartley

Stoke Newington, London, 2026